RedHill Biopharma (RDHL) Prices 2.14M Share Offering at $0.58/sh

Go back to RedHill Biopharma (RDHL) Prices 2.14M Share Offering at $0.58/sh

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price

April 2, 2024 7:00 AM EDT

TEL AVIV, Israel and RALEIGH, N.C., April 2, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into definitive agreements with... More